Department of Anaesthesia, Western General Hospital, Edinburgh, Scotland.
Eur J Anaesthesiol. 2010 Jan;27(1):11-5. doi: 10.1097/EJA.0b013e32832f0878.
Patients commonly take a combination of prescription drugs and herbal medicines. Often these alternative products have known pharmacological effects which may interact with drugs given perioperatively, resulting in adverse events. They can also cause physiological fluctuations which may influence the choice of anaesthetic technique used. This has been acknowledged by a number of national bodies that recommend eliciting a history of herbal medicine use preoperatively. This survey attempted to ascertain whether this guidance had been observed and turned into local policy. We also attempted to determine what advice patients were being given.
Three hundred and twenty-one questionnaires were sent to all United Kingdom hospitals with an Anaesthetic Department in September 2006. Reminders were then sent to those recipients who did not respond.
Replies were received from 233 (72.6%) anaesthetic departments. Seventeen (7.3%) departments have a perioperative herbal medicine policy in place and a further six had plans to develop one. The majority (98.3%) of departments did not have a specific section for documenting herbal medicine use on their an aesthetic records. Of the departments that held pre-assessment clinics, 34 (15.7%) asked patients routinely about herbal medicine use, and the advice given regarding the use of herbal medicines was varied, and generally, not in accordance with existing guidelines.
Anaesthetic departments in the United Kingdom are not currently following national advice regarding herbal medicine use. There is no coherence in the advice being offered to patients in the perioperative period, which may reflect the lack of information available. National guidelines may help clinicians understand the issues and adopt best practice.
患者通常会同时服用处方药物和草药。这些替代产品通常具有已知的药理学作用,可能会与围手术期给予的药物相互作用,导致不良事件。它们还可能引起生理波动,从而影响所选择的麻醉技术。许多国家机构已经认识到这一点,建议在术前询问患者草药使用史。本调查试图确定是否遵循了这一指南并将其转化为当地政策。我们还试图确定患者正在接受哪些建议。
2006 年 9 月,向英国所有设有麻醉科的医院发送了 321 份问卷。然后,向未回复的收件人发送了提醒。
233 个(72.6%)麻醉科部门回复了。17 个(7.3%)部门制定了围手术期草药政策,另有 6 个部门计划制定该政策。大多数(98.3%)部门在麻醉记录上没有专门记录草药使用的部分。在设有术前评估诊所的部门中,有 34 个(15.7%)常规询问患者草药使用情况,提供的关于草药使用的建议各不相同,通常与现有指南不一致。
英国的麻醉科部门目前没有遵循关于草药使用的国家建议。在围手术期为患者提供的建议没有一致性,这可能反映了缺乏可用信息。国家指南可以帮助临床医生了解问题并采用最佳实践。